NO20054032L - Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. - Google Patents
Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene.Info
- Publication number
- NO20054032L NO20054032L NO20054032A NO20054032A NO20054032L NO 20054032 L NO20054032 L NO 20054032L NO 20054032 A NO20054032 A NO 20054032A NO 20054032 A NO20054032 A NO 20054032A NO 20054032 L NO20054032 L NO 20054032L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- unsubstituted
- preparation
- intermediates
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/04—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003037397 | 2003-02-14 | ||
PCT/JP2004/001566 WO2004072091A1 (ja) | 2003-02-14 | 2004-02-13 | 糖脂質誘導体及びその製造法並びにそれらの合成中間体及びその製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054032D0 NO20054032D0 (no) | 2005-08-30 |
NO20054032L true NO20054032L (no) | 2005-11-01 |
Family
ID=32866358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054032A NO20054032L (no) | 2003-02-14 | 2005-08-30 | Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. |
Country Status (12)
Country | Link |
---|---|
US (2) | US7732583B2 (es) |
EP (2) | EP1619199B1 (es) |
JP (2) | JP4742220B2 (es) |
KR (1) | KR20050105215A (es) |
CN (2) | CN101165047B (es) |
AU (1) | AU2004210784A1 (es) |
BR (1) | BRPI0407501A (es) |
CA (1) | CA2515396A1 (es) |
ES (2) | ES2676345T3 (es) |
HU (1) | HUE037560T2 (es) |
NO (1) | NO20054032L (es) |
WO (1) | WO2004072091A1 (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9809654B2 (en) | 2002-09-27 | 2017-11-07 | Vaccinex, Inc. | Targeted CD1d molecules |
EP1784196B1 (en) * | 2004-08-27 | 2016-12-21 | Albert Einstein College Of Medicine Of Yeshiva University | Ceramide derivatives as modulators of immunity and autoimmunity |
US7923013B2 (en) | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
JP5090928B2 (ja) * | 2004-12-28 | 2012-12-05 | ザ ロックフェラー ユニバーシティ | Nkt細胞に対する抗原としての糖脂質及びその類似体 |
US20090227781A1 (en) * | 2005-07-01 | 2009-09-10 | Sachiko Miyake | Glycolipid Derivative and Drug Containing the Same as Active Component |
WO2008047174A1 (en) * | 2006-10-18 | 2008-04-24 | Centre National De La Recherche Scientifique | Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
CA2678618C (en) * | 2007-02-21 | 2019-03-12 | Vaccinex, Inc. | Modulation of nkt cell activity with antigen-loaded cd1d molecules |
EP2385980B1 (en) * | 2009-01-08 | 2018-04-18 | Albert Einstein College of Medicine, Inc. | Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof |
CN101775051B (zh) * | 2010-01-07 | 2013-03-27 | 北京大学 | 一种区域选择性脱除糖o-苄基保护基的方法 |
US10632740B2 (en) | 2010-04-23 | 2020-04-28 | Landa Corporation Ltd. | Digital printing process |
JP6328571B2 (ja) | 2012-03-05 | 2018-05-23 | ランダ コーポレイション リミテッド | 剥離層の処理 |
US9902147B2 (en) | 2012-03-05 | 2018-02-27 | Landa Corporation Ltd. | Digital printing system |
CN104271356B (zh) | 2012-03-05 | 2016-10-19 | 兰达公司 | 数字印刷工艺 |
US10190012B2 (en) | 2012-03-05 | 2019-01-29 | Landa Corporation Ltd. | Treatment of release layer and inkjet ink formulations |
US9498946B2 (en) | 2012-03-05 | 2016-11-22 | Landa Corporation Ltd. | Apparatus and method for control or monitoring of a printing system |
WO2013136220A1 (en) | 2012-03-15 | 2013-09-19 | Landa Corporation Limited | Endless flexible belt for a printing system |
WO2015036960A1 (en) | 2013-09-11 | 2015-03-19 | Landa Corporation Ltd. | Release layer treatment formulations |
US10642198B2 (en) | 2012-03-05 | 2020-05-05 | Landa Corporation Ltd. | Intermediate transfer members for use with indirect printing systems and protonatable intermediate transfer members for use with indirect printing systems |
AU2013229140B2 (en) | 2012-03-05 | 2017-02-02 | Landa Corporation Ltd. | Ink film constructions |
AU2013229142B2 (en) | 2012-03-05 | 2017-02-02 | Landa Corporation Ltd. | Ink film constructions |
US9643403B2 (en) | 2012-03-05 | 2017-05-09 | Landa Corporation Ltd. | Printing system |
US10434761B2 (en) | 2012-03-05 | 2019-10-08 | Landa Corporation Ltd. | Digital printing process |
US9371352B2 (en) | 2013-02-08 | 2016-06-21 | Vaccinex, Inc. | Modified glycolipids and methods of making and using the same |
AU2014214770B2 (en) | 2013-02-08 | 2018-09-06 | Albert Einstein College Of Medicine Inc. | Modified glycolipids and methods of making and using the same |
GB201401173D0 (en) | 2013-09-11 | 2014-03-12 | Landa Corp Ltd | Ink formulations and film constructions thereof |
GB2536489B (en) | 2015-03-20 | 2018-08-29 | Landa Corporation Ltd | Indirect printing system |
GB2537813A (en) | 2015-04-14 | 2016-11-02 | Landa Corp Ltd | Apparatus for threading an intermediate transfer member of a printing system |
JP7144328B2 (ja) | 2016-05-30 | 2022-09-29 | ランダ コーポレイション リミテッド | デジタル印刷処理 |
GB201609463D0 (en) | 2016-05-30 | 2016-07-13 | Landa Labs 2012 Ltd | Method of manufacturing a multi-layer article |
JP7206268B2 (ja) | 2017-10-19 | 2023-01-17 | ランダ コーポレイション リミテッド | 印刷システム用の無端可撓性ベルト |
JP7225230B2 (ja) | 2017-11-19 | 2023-02-20 | ランダ コーポレイション リミテッド | デジタル印刷システム |
US11511536B2 (en) | 2017-11-27 | 2022-11-29 | Landa Corporation Ltd. | Calibration of runout error in a digital printing system |
US11707943B2 (en) | 2017-12-06 | 2023-07-25 | Landa Corporation Ltd. | Method and apparatus for digital printing |
WO2019111223A1 (en) | 2017-12-07 | 2019-06-13 | Landa Corporation Ltd. | Digital printing process and method |
IL279556B2 (en) | 2018-06-26 | 2024-06-01 | Landa Corp Ltd | Part for intermediate transfer to a digital printing system |
US10994528B1 (en) | 2018-08-02 | 2021-05-04 | Landa Corporation Ltd. | Digital printing system with flexible intermediate transfer member |
WO2020035766A1 (en) | 2018-08-13 | 2020-02-20 | Landa Corporation Ltd. | Correcting distortions in digital printing by implanting dummy pixels in a digital image |
WO2020075012A1 (en) | 2018-10-08 | 2020-04-16 | Landa Corporation Ltd. | Friction reduction means for printing systems and method |
EP3902680A4 (en) | 2018-12-24 | 2022-08-31 | Landa Corporation Ltd. | DIGITAL PRINTING SYSTEM |
WO2021105806A1 (en) | 2019-11-25 | 2021-06-03 | Landa Corporation Ltd. | Drying ink in digital printing using infrared radiation absorbed by particles embedded inside itm |
US11321028B2 (en) | 2019-12-11 | 2022-05-03 | Landa Corporation Ltd. | Correcting registration errors in digital printing |
JP2023508513A (ja) | 2019-12-29 | 2023-03-02 | ランダ コーポレイション リミテッド | 印刷方法およびシステム |
WO2022102557A1 (ja) * | 2020-11-12 | 2022-05-19 | 国立研究開発法人理化学研究所 | 擬似糖脂質誘導体並びにその合成中間体、製造方法及び用途 |
CA3212136A1 (en) | 2021-03-01 | 2022-09-09 | Deciduous Therapeutics, Inc. | Compounds for activating invariant natural killer t-cells and methods of use in eliminating inflammatory senescent cells |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6072960A (ja) * | 1983-09-30 | 1985-04-25 | Sumitomo Chem Co Ltd | モノアゾ化合物およびそれを用いて染色または捺染する方法 |
JPH0559081A (ja) * | 1991-08-29 | 1993-03-09 | Kirin Brewery Co Ltd | 新規スフインゴ糖脂質、その製造法および使用 |
US5936076A (en) * | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
DE69328435T2 (de) * | 1992-10-22 | 2000-09-14 | Kirin Beer K.K., Tokio/Tokyo | Neues sphingolglycolipid und verwendung davon |
JP2002226377A (ja) | 1996-10-14 | 2002-08-14 | Kirin Brewery Co Ltd | 配糖体含有末梢血幹細胞増加剤 |
TW592703B (en) * | 1997-04-10 | 2004-06-21 | Kirin Brewery | NKT cell-activating agents containing alpha-glycosylceramides |
CN100439383C (zh) * | 2001-08-16 | 2008-12-03 | 阿斯比奥制药株式会社 | 糖脂及其作为有效成分的用于自体免疫疾病的药物 |
-
2004
- 2004-02-13 KR KR1020057014984A patent/KR20050105215A/ko not_active Application Discontinuation
- 2004-02-13 EP EP04710993.9A patent/EP1619199B1/en not_active Expired - Lifetime
- 2004-02-13 HU HUE11160814A patent/HUE037560T2/hu unknown
- 2004-02-13 US US10/545,421 patent/US7732583B2/en active Active
- 2004-02-13 EP EP11160814.7A patent/EP2343306B1/en not_active Expired - Lifetime
- 2004-02-13 ES ES11160814.7T patent/ES2676345T3/es not_active Expired - Lifetime
- 2004-02-13 AU AU2004210784A patent/AU2004210784A1/en not_active Abandoned
- 2004-02-13 BR BRPI0407501-3A patent/BRPI0407501A/pt not_active IP Right Cessation
- 2004-02-13 JP JP2005505007A patent/JP4742220B2/ja not_active Expired - Lifetime
- 2004-02-13 CN CN2007101544258A patent/CN101165047B/zh not_active Expired - Lifetime
- 2004-02-13 WO PCT/JP2004/001566 patent/WO2004072091A1/ja active Application Filing
- 2004-02-13 CA CA002515396A patent/CA2515396A1/en not_active Abandoned
- 2004-02-13 CN CNB200480004216XA patent/CN100537585C/zh not_active Expired - Lifetime
- 2004-02-13 ES ES04710993.9T patent/ES2450043T3/es not_active Expired - Lifetime
-
2005
- 2005-08-30 NO NO20054032A patent/NO20054032L/no not_active Application Discontinuation
-
2010
- 2010-04-15 US US12/760,793 patent/US8034908B2/en not_active Expired - Fee Related
- 2010-10-12 JP JP2010229896A patent/JP5246448B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN100537585C (zh) | 2009-09-09 |
BRPI0407501A (pt) | 2006-02-14 |
HUE037560T2 (hu) | 2018-09-28 |
US20100210828A1 (en) | 2010-08-19 |
ES2676345T3 (es) | 2018-07-18 |
EP1619199A4 (en) | 2009-12-16 |
CA2515396A1 (en) | 2004-08-26 |
CN1768072A (zh) | 2006-05-03 |
JP2011063593A (ja) | 2011-03-31 |
US7732583B2 (en) | 2010-06-08 |
US8034908B2 (en) | 2011-10-11 |
WO2004072091A1 (ja) | 2004-08-26 |
US20060074235A1 (en) | 2006-04-06 |
WO2004072091B1 (ja) | 2004-11-11 |
JP5246448B2 (ja) | 2013-07-24 |
EP1619199B1 (en) | 2013-12-18 |
NO20054032D0 (no) | 2005-08-30 |
EP1619199A1 (en) | 2006-01-25 |
JPWO2004072091A1 (ja) | 2006-06-01 |
AU2004210784A1 (en) | 2004-08-26 |
EP2343306B1 (en) | 2018-04-04 |
EP2343306A1 (en) | 2011-07-13 |
ES2450043T3 (es) | 2014-03-21 |
CN101165047B (zh) | 2010-10-20 |
JP4742220B2 (ja) | 2011-08-10 |
CN101165047A (zh) | 2008-04-23 |
KR20050105215A (ko) | 2005-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054032L (no) | Glykolipidderivater, fremgangsmate for fremstilling derav, mellomprodukter for fremstilling derav oq fremgangsmater for fremstilling av mellomproduktene. | |
EP1845081A4 (en) | amide | |
DE60301345D1 (de) | Stabilisierte askorbinsäurederivate | |
BG108174A (en) | 5-phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi | |
HUP0300080A2 (hu) | Új malonsavszármazékok, eljárás előállításukra, ezek alkalmazása Xa faktor inhibitorként és ezeket tartalmazó gyógyszerkészítmények | |
NO20085140L (no) | Nye indazolderivater som har spiro ringstruktur i sidekjede | |
DK1008592T3 (da) | Cykliske amidderivater, som inhiberer cathepsin K | |
MY143665A (en) | Method of producing aminophenol compounds. | |
EP1634874A4 (en) | imidazolidine | |
NO20031701L (no) | Fremgangsmåte og mellomprodukter i fremstilling av 7- substituerte antiöstrogener | |
NO20062083L (no) | Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20055167L (no) | Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20013643L (no) | Fremgangsmåte for fremstilling av optisk aktiv alkohol | |
TW200619201A (en) | Process for the preparation of pyrazoles | |
NO20082698L (no) | Nye derivater, deres salter og antisoppmidler inneholdende disse | |
NO20091779L (no) | Nye indolforbindelser en prosess for deres fremstilling og farmasoytiske sammensetninger som inneholder dem | |
NO20082005L (no) | Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon | |
NO20060258L (no) | Nematicidale tiazolin-inneholdende fluorobutener | |
NO20062100L (no) | Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
DE60313798D1 (en) | Halothienoylcyclopropan-1-carbonsaeure-derivate | |
AR058839A1 (es) | Derivados de piperidina, utiles para el tratamiento de enfermedades proliferativas | |
AU6594900A (en) | Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents | |
BRPI0506548A (pt) | métodos para produzir compostos de 4-tetrazolil-4-fenilpiperidina | |
NO20045540L (no) | Nye 3-(4-okso-4H-kromen-2-yl)-(1H)-kinolin-4-on-forbindelser, en fremgangsmate for deres fremstilling og farmasoytisk sammensetninger inneholdende dem | |
HUP0303686A2 (hu) | Eljárás Delta1-pirrolin-származékok előállítására és az új intermedierek |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |